Gastroenterology

Eur Rev Med Pharmacol Sci 2016; 20 (7): 1315-1322

Is there any association between irritable bowel syndrome subgroups and autonomous dysfunction

A.E. Yildirim, M. Korkmaz, R. Altun, S.C. Sandikçi, S. Ocal, H. Selçuk
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (6): 1052-1056

Epidemiological characteristics and risk factors of hepatitis C virus genotype 1 infection: a national epidemiological survey of Chinese Han population

C.-B. Wang, Z.-X. Cheng, J.-J. Chen, Y.-Y. Chen, H.-M. Nie, Q.-H. Ling, Y.-N. Dong
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (6): 1044-1051

Prioritization of high-cost new drugs for HCV: making sustainability ethical

L. Craxì, D. Sacchini, P. Refolo, R. Minacori, V. Daloiso, G. Ricci, R. Bruno, C. Cammà, A. Cicchetti, A. Gasbarrini, A.G. Spagnolo
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (6): 1037-1043

Quantitative fibrosis parameters highly predict esophageal-gastro varices in primary biliary cirrhosis

Q.-M. Wu, X.-Y. Zhao, H. You
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 879-885

Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole

A. Ormeci, Z. Emrence, B. Baran, S. Gokturk, O.M. Soyer, S. Evirgen, F. Akyuz, C. Karaca, F. Besisik, S. Kaymakoglu, D. Ustek, K. Demir
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 873-878

Early blood purification therapy of severe acute pancreatitis complicated by acute lung injury

H. Guo, D.-W. Suo, H.-P. Zhu, X.-M. Sun, J. Chen
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 866-872

Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis

G.-L. Wang, Y. Liu, P. Qiu, S.-F. Zhou, L.-F. Xu, P. Wen, J.-B. Wen, X.-Z. Xiao
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 858-865

Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

A.C. Ormeci, F. Akyuz, B. Baran, O.M. Soyer, S. Gokturk, M. Onel, D. Onel, A. Agacfidan, M. Demirci, G. Yegen, M. Gulluoglu, C. Karaca, K. Demir, F. Besisik, S. Kaymakoglu
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (4): 685-688

Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature

L. Laterza, A.C. Piscaglia, S. Lecce, A. Gasbarrini, M.L. Stefanelli
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (3): 486-490

Uptake characteristics of levofloxacin for the eradication of Helicobacter pylori by GES-1 and MGC80-3 cells

Y.-M. Hu, X.-P. Hu, L. Zhang, S.-S. Zhang, J.-M. Xu
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (3): 476-485

Anti-reflux anastomosis following esophagectomy for adenocarcinoma of the esophagogastric junction: impact of duodenogastroesophageal reflux and expression of cyclooxygenase-2 in the remnant esophagus

J.-D. Wang, S.-Y. Zhu, Y.-J. Lu, L.-Y. Gao
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (2): 297-300

High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection

F. Franceschi, V. Ojetti, M. Gabrielli, C. Petruzziello, A. Tortora, G. Gasbarrini, L.R. Lopetuso, F. Scaldaferri, A. Gasbarrini
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (2): 291-296

The correlation between Doppler US measurement of hepatic arterial flow and the MELD score in patients with chronic liver disease

N.B. Topal, P. Sarkut, H.Z. Dündar, A.U. Şahin, İ. Ercan, T. Ayyıldız, R. İşçimen, M. Kiyici, E. Kaya, R. Emiroglu
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (2): 285-290

Laparoscopic treatment experience of severe acute pancreatitis complicated by peptic ulcer perforation

J.-Y. Sun, D.-J. Sun, X.-J. Li, K. Jiao, Z.-W. Zhai
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (1 Suppl): 17-19

Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis Network

A. Aghemo, R. Bruno, M. Colombo, M. Medagli, M. Puoti, G. Rizzardini, S. Fagiuoli; on behalf of the Lombardia Hepatitis Network
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (1 Suppl): 11-16

The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases

F. Cartabellotta, V. Di Marco; on behalf of RESIST - HCV
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (1 Suppl): 7-10

HCV – Estimation of the number of diagnosed patients eligible to the new anti-HCV therapies in Italy

I. Gardini, M. Bartoli, M. Conforti, F.S. Mennini, A. Marcellusi, E. Lanati
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (1 Suppl): 4-6

HCV – Treatment ratio and governance footprints: analysis of regional differentiation in Italy

E. Lanati, A. Marcelli
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (1 Suppl): 1-3

The healthcare service in Italy: regional variability

A. Cicchetti, A. Gasbarrini
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (1): 3-4

Comment on “The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia”

J. Kountouras, E. Tsiaousi, S. Trigonis, S.A. Polyzos, P. Katsinelos, C. Zavos, E. Vardaka, C. Kountouras, E. Gavalas, K. Anastasiadou, E. Vlachaki, M. Boziki, C. Zeglinas, I. Venizelos, G. Deretzi
Free PDF Download